EFFECT OF GROWTH HORMONE AND IGF-1 ON NEURAL STEM CELLS

Details for Australian Patent Application No. 2002325710 (hide)

Owner STEM CELL THERAPEUTICS INC.

Inventors WEISS, Samuel; SHINGO, Tetsuro

Pub. Number AU-A-2002325710

PCT Number PCT/CA02/01344

PCT Pub. Number WO2003/024471

Priority 60/386,404 07.06.02 US; 60/323,503 18.09.01 US

Filing date 30 August 2002

Wipo publication date 1 April 2003

International Classifications

A61K 038/00 Medicinal preparations containing peptides

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): 60/386,404 07.06.02 US; 60/323,503 18.09.01 US

5 June 2003 Application Open to Public Inspection

  Published as AU-A-2002325710

10 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002325711-Prolactin induced increase in neutral stem cell numbers and therapeutical use thereof

2002325709-GENERATION OF TRANSGENIC MOUSE MODELS FOR THE DEVELOPMENT OF PROSTATE CANCER USING REGULATORY REGIONS OF THE PSP94 GENE